Abstract: A system includes a processor configured to generate stimulation control signals in response to a detection of a respiratory disorder. The system further includes at least one kinesthetic effector with a vibrating electromechanical transducer applied to a site on a patient's skin for delivering a kinesthetic stimulation energy determined by the control signals. The processor is further configured to determine the effectiveness of a stimulation by detecting a cessation of the respiratory disorder. The processor is further configured to extend the stimulation control signals for a determined duration following the cessation of the respiratory disorder.

Abstract: A system includes a processor configured to generate stimulation control signals in response to a detection of a respiratory disorder. The system further includes at least one kinesthetic effector with a vibrating electromechanical transducer applied to a site on a patient's skin for delivering a kinesthetic stimulation energy determined by the control signals. The processor is further configured to determine the effectiveness of a stimulation by detecting a disappearance of the respiratory disorder. The processor is further configured to determine a therapy by selecting a stimulation strategy among several stimulation strategies according to a type of expected or detected disorder.

Abstract: A device includes a processor configured to detect a respiratory disorder episode and generate kinesthetic stimulation control signals in response to the detection of a respiratory disorder episode. The device further includes at least one kinesthetic effector adapted to be applied to a patient's outer skin site and includes a vibrating electromechanical transducer capable of receiving stimulation control signals and outputting a kinesthetic stimulation energy determined by the stimulation control signals. The processor is further configured to determine the effectiveness of stimulation by detecting a cessation of the respiratory disorder episode. The processor is further configured to determine a stimulation energy by selecting an initial energy value and varying the energy value as a function of the effectiveness of previous stimulation.

Abstract: Multimenic lectins having a ?-propeller architecture, formed from monomer modules of approximately 30 to 60 amino acids, in which the binding sites to the glycans are situated on a given side of the proteins and the O-terminus and N-terminus ends of the peptide chains on the other side of the proteins, characterized in that they are formed from 4 to 7 monomer modules, a single, or a plurality of, or all of the adjacent modules being linked to one another by the linkers linking the N-terminus end of one module to the C-terminus end of the adjacent module.

Abstract: A method for producing a film including a non-magnetic matrix and a plurality of three-dimensional magnetic microstructures arranged within the matrix according to a predetermined pattern. The method includes providing a master substrate with a magnetically structured face formed from a plurality of magnetic field micro-sources, having a magnetic field gradient of between 102 and 106 T/m. The method also includes adding magnetic microparticles or nanoparticles to the magnetically structured face of the master substrate, the particles agglomerating into three-dimensional microstructures arranged under an effect of an attractive magnetophoretic force exerted by the magnetic field gradient on the surface of the master substrate. The method further includes depositing, on the magnetically structured face of the master substrate, a matrix made from a non-magnetic material, in such a way as to enclose the arranged microstructures and to form the film and peeling the film from the master substrate.

Abstract: The present invention concerns a method for the preparation of a catalyst onto a solid support of a (semi-)conductive material consisting in depositing said catalyst onto said support from a near-neutral aqueous solution containing at least one nickel or cobalt organic complex and at least one basic oxoanion, by a method selected in the group consisting of reductive electrodeposition, photochemical electrodeposition and photoelectrochemical deposition. The present invention also concerns said catalyst and uses thereof.

Abstract: A process of manufacturing component with a composite film including a matrix made of thermoplastic polymer and particles inside this matrix. This process includes heating the composite film in order for its temperature to exceed the glass transition temperature of its matrix, then when the composite film is softened, flattening an external face of the composite film by a smooth face resting directly over the whole of this external face, this smooth face forming part of the front face of a flexible membrane, the whole of the rear face of which, located on the side opposite the front face, is pushed against the composite film by a fluid, then cooling the composite film below the glass transition temperature, then withdrawing the membrane in order to mechanically separate its front face from the external face of the composite film.

Abstract: A process for the specific isotopic labeling of an amino acid selected from Valine (Val), Leucine (Leu), and Isoleucine (Ile), in proteins and biomolecular assemblies by introducing, in a medium containing bacteria overexpressing a protein, an acetolactate derivative of Formula I of the application.

Abstract: In one embodiment of the present invention, a method is provided for assisting cartilage diagnostic and therapeutic procedures and includes the steps of acquiring 3D osteocartilaginous parameters by using multimodal 3D tracked devices; incorporating these parameters into a volumic anatomic osteocartilaginous model from which a bone tracking virtual real-time environment is built; three-dimensionally computing an osteocartilaginous quality score from this multiparametric 3D osteocartilaginous model; providing real-time navigation in this 3D virtual environment in order to make ongoing therapeutic assessments and adjustments; and updating steps 1 to 3 according to the performed therapy. It will be appreciated that the above steps are compatible with arthroscopic procedures involving cartilage.

Abstract: A supercapacitor to be submerged in a medium containing a biological material and an oxidant, wherein the anode comprises a first enzyme that can catalyse the oxidation of the biological material and the cathode comprises a second enzyme that can catalyse the reduction of the oxidant, and wherein each of the anode and cathode electrodes consists of a solid agglomerate of a conductive material mixed with the first or the second enzyme, said agglomerate having a specific surface that is larger than or equal to 20 m2/g and an average pore size varying between 0.7 nm and 10 pm.

Abstract: A device for controlling blood flow occurring in a haemorrhagic zone of a biological tissue, includes a flexible plate arranged to be placed opposite this zone, the flexible plate including: substantially leaktight peripheral supporting elements, for applying on the tissue so that the zone is surrounded; a back wall delimiting, with the supporting elements, opposite the zone, a hollow space; connecting elements connecting the hollow space, externally to the flexible plate, to an external aspiration source for creating a vacuum in the hollow space for aspirating and tightly applying the surface of the tissue against the peripheral supporting elements; and a hollow stud placed between the zone and the back wall and hollowed out in its center on the side of the zone along an axis substantially perpendicular to the back wall, and arranged to be in contact with the zone when the vacuum is created in the space.

Abstract: The invention relates to novel cyclodecapeptide compounds having formula (I) for use as drugs and, more specifically, for use in the diagnosis, prevention and/or treatment of neurodegenerative diseases, such as Wilson's disease and Alzheimer's disease, and for use in the diagnosis, prevention and/or treatment of poisoning with metal ions, such as copper and mercury ions. The invention also relates to pharmaceutical compositions comprising at least one compound having formula (I) as an active principle.

Abstract: Device (10) for depositing particles via the liquid route including a first chamber a second chamber (12), a communication hole between the first chamber (11) and the second chamber (12), and a vent which is provided in the second chamber and which places the second chamber and a medium (200) which is external with respect to the device in communication.

Abstract: The present invention relates to a method for producing a molecule of interest in bacteria which is based on a reversible growth arrest of the bacteria at the cellular growth global control system level, thus allowing an improved yield of production of said molecule of interest.

Abstract: The method for automated manufacturing of an electronic circuit tolerant to faults by temporal redundancy of maximum order N, comprising a step implemented by computer, according to which every memory cell of the circuit is replaced by a memory block (40) comprising a chain of memory cells in series, and a selection block which, in a temporal redundancy mode of order n1, n1?[1,N], selects as output data of the memory block the majority content of n1 cells of the block, and can furthermore deliver a fault signal if the contents of the n1 cells differ. Said method is characterized in that the inserted memory blocks allow a dynamic switching from a temporal redundancy mode of order n1 to any other mode of order n2. Said method for N=2, in association with a mechanism for recording with roll-back, allows an error with only a double redundancy instead of a triple redundancy.

Abstract: The invention relates to a process for the specific isotopic labeling of Valine, Leucine and Isoleucine amino acids. The process of the invention uses a 2-alkyl-2-hydroxy-3-oxobutanoic acid in which the alkyl substituent in position 2 is ethyl or methyl. The invention can be used for the analysis of proteins, in particular by NMR.

Abstract: A protein complex isolated from its natural medium and including the ZEBRA protein of sequence SEQ ID NO: 1, the isolated protein complex having the following properties: it is more stable than the ZEBRA protein, in particular it is more resistant to the action of the proteases than the ZEBRA protein, it is capable of specifically binding the AZ125 and AZ130 monoclonal antibodies, it is soluble in a body fluid, and in particular a body fluid selected from the group constituted by blood and serum, and to its detection process and the uses of this process for the prognosis or diagnosis of lymphoproliferative episodes associated with the EBV.

Abstract: Device for haemostatic control of a blood flow, comprising a suction cup which provides leaktight coverage and is able to surround and be applied tightly to a tissue area (2) that is to be treated, said tissue area (2) being the site of a haemorrhage or of a blood flow that is to be controlled, this suction cup (3) coming into contact with the periphery of the tissue area and delimiting an internal volume (8) which is connected in a leaktight manner, by a catheter or a similar connecting tube (7), to an external aspiration element that establishes a vacuum, so as to create an underpressure of defined value within this volume between the suction cup and the tissue area, the suction cup (3) having the general shape of a dome (4), of which the base (5) supports an inner bearing element (11) that can be arranged opposite the tissue area (2) under the suction cup (3). The invention lies in the inner bearing element being formed by a solid obturator (11) or an open grill (13).

Abstract: Novel bis-indolic derivatives, processes for their preparation, and their potential use as new antibacterial drugs.

Abstract: Method for monitoring an electrochemical cell or a battery (1), in particular method for monitoring the first charging of an electrochemical cell or of a battery (1) of Li-ion type, comprising a step of acquiring data relating to acoustic emissions produced in the electrochemical cell or in the battery and, by using the data acquired, a step of detecting: the formation of a passivation film on an electrode of the electrochemical cell or of the battery; and/or the first storage of lithium in an electrode of the electrochemical cell or of the battery.